From GlobeNewswire: 2025-05-30 09:35:00

The global continuous glucose monitoring devices market is growing due to the rising demand for diabetes management and OTC products. The market is expected to reach US$ 32.97 billion by 2031, with a CAGR of 12.6% from 2024. CGM devices provide real-time updates on blood sugar levels, aiding in better management.

The increasing need for effective diabetes management is highlighted by the global rise in diabetes cases, especially type 2. The use of CGM devices offers real-time insights to adjust dietary choices and insulin doses, reducing the risk of hypoglycemia and hyperglycemia. The surge in OTC products has made glucose monitoring more accessible and affordable.

Market segmentation of continuous glucose monitoring devices includes sensors, transmitters, and receivers. Fingertip testing holds a larger share, with applications in type-1 and type-2 diabetes, primarily used in hospitals and clinics. North America led the market in 2024, with Asia Pacific expected to have the highest CAGR.

Key players in the market include B. Braun SE, Medtronic, Abbott Laboratories, and others. Trending topics include AI in CGM devices and OTC products for glucose management. Recent developments include partnerships for non-invasive devices and new CGM launches.

Philips-Medisize partnered with GlucoModic for a non-invasive glucose monitoring device. Medtronic received CE Mark approval for the MiniMed 780G system with Simplera Sync. Dexcom launched the Dexcom G7, the smallest CGM connected to the t:slim X2 pump. Roche received CE Mark for the Accu-Chek SmartGuide CGM.

The CGM market growth is driven by the rising prevalence of diabetes and the use of OTC products for self-management. Technological advancements and increased accessibility have democratized glucose monitoring, expanding the industry. The shift towards OTC availability has empowered users and fostered long-term market growth.



Read more at GlobeNewswire: Continuous Glucose Monitoring Devices Market Size expected